Group 1 - The company, Beijing Succeeder Technology Co., Ltd., will hold a performance briefing for the first half of 2025 on September 17, 2025, from 15:00 to 17:00 [1][2] - The briefing will be conducted in an online interactive format via the Shanghai Stock Exchange Roadshow Center [2][3] - Investors can submit questions in advance from September 10 to September 16, 2025, and the company will address commonly asked questions during the session [2][3] Group 2 - Key participants in the briefing will include the company's General Manager Wang Hai, Deputy General Manager Ding Zhonghui, and other board members [2] - The contact information for inquiries includes the Board Office's phone number and email address [3]

Core Points - The company, Wuxi Chison Medical Technology Co., Ltd., will hold a collective performance briefing for the medical device industry on September 17, 2025, from 15:00 to 17:00 [1][2] - The briefing aims to provide investors with a comprehensive understanding of the company's operating results and financial status for the first half of 2025 [1] - The event will be conducted in an interactive text format via the Shanghai Stock Exchange's online platform [2][3] Meeting Details - The meeting will take place at the Shanghai Stock Exchange Roadshow Center [2][3] - Key participants include the Chairwoman and General Manager, Mo Ruoli, along with other board members and the investor relations officer [2] - Investors can participate online and submit questions from September 10 to September 16, 2025, prior to the meeting [2][3] Contact Information - The company’s securities affairs department can be contacted at 0510-85271380 or via email at info@chison.com.cn for further inquiries [3]

Group 1 - The company will participate in the 2025 semi-annual performance briefing for the medical device industry on September 17, 2025, from 15:00 to 17:00 [1][2] - The briefing will be held at the Shanghai Stock Exchange Roadshow Center and will be conducted via video live streaming and online interaction [1][2] - Investors can submit questions from September 10 to September 16, 2025, before 16:00, through the Roadshow Center website or via the company's email [3] Group 2 - Key participants in the briefing include Chairman Eric Gang Hu, General Manager and Secretary of the Board Qiu Zhiye, and Chief Financial Officer Wang Ling [2] - After the briefing, investors can view the meeting details and main content on the Shanghai Stock Exchange Roadshow Center [4]

Core Viewpoint - The company will hold an investor briefing on September 17, 2025, to discuss its 2025 semi-annual report and address investor inquiries [2][3][4]. Group 1: Meeting Details - The investor briefing is scheduled for September 17, 2025, from 15:00 to 17:00 [4]. - The meeting will take place at the Shanghai Stock Exchange Roadshow Center, accessible online [4]. - The format of the meeting will be an interactive online session [3][4]. Group 2: Participation Information - Investors can participate in the briefing by logging into the Shanghai Stock Exchange Roadshow Center on the meeting day [4]. - Questions can be submitted from September 10 to September 16, 2025, through the Roadshow Center website or via the company's email [4][5]. - The company will address commonly asked questions during the briefing [3][5]. Group 3: Company Representatives - Key representatives attending the meeting include the General Manager, Chief Financial Officer, Board Secretary, and an Independent Director [4].

Group 1 - The company Huada Zhi Zao announced its participation in the 2025 semi-annual performance briefing for the medical device industry on September 17, 2025 [2]

Group 1 - The company will hold a collective performance briefing for the medical device industry on September 17, 2025, from 15:00 to 17:00 [1][2] - The briefing will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an online interactive format [2][3] - Investors can submit questions from September 10 to September 16, 2025, before 16:00, through the Roadshow Center website or via the company's email [3] Group 2 - Key personnel attending the briefing include the General Manager, Chief Financial Officer, Board Secretary, and an Independent Director [2] - After the briefing, investors can access the main content and details of the event through the Roadshow Center [3]

Core Viewpoint - The company will participate in the 2025 semi-annual performance briefing for the medical device industry on September 17, 2025, to discuss its operational results and financial status with investors [1][2]. Group 1: Meeting Details - The meeting is scheduled for September 17, 2025, from 15:00 to 17:00 [2][3]. - The location of the meeting is the Shanghai Stock Exchange Roadshow Center, accessible online [2][3]. - The format of the meeting will be an online interactive session [2][3]. Group 2: Participation Information - Investors can participate in the meeting by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date [3]. - Investors are encouraged to submit questions from September 10 to September 16, 2025, via the designated email or the online platform [3]. - The company will address commonly asked questions during the briefing [3]. Group 3: Attendees - Key attendees include Dr. Zhu Qing (CEO), Mr. Ye Xiaojie (Independent Director), Mr. Liu Hao (VP of Treatment Solutions), Mr. Qiu Genyong (Secretary of the Board), and Ms. Li Chunfang (Senior Financial Director) [2].